Simplify Logo

Full-Time

Senior Director Market Research

Posted on 5/28/2024

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Consulting
Biotechnology

Senior, Expert

San Diego, CA, USA

Category
General Marketing
Growth & Marketing
Required Skills
Market Research
Requirements
  • Bachelor's degree in business, management science, market research, or related field required
  • MBA highly preferred
  • 12+ years of progressively responsible experience in market research
  • Experience leading market research for in-line products
  • Deep knowledge of brand management related to healthcare industry
  • Strong understanding of secondary data and analysis
  • Demonstrated ability to work in a dynamic, fast-paced team-oriented environment
  • Negotiating skills
  • Strong presentation and communication skills
Responsibilities
  • Leading and integrating primary and secondary market research insights
  • Developing actionable insights, conclusions, and recommendations
  • Leading the design and execution of market research with key customer groups
  • Supervising the market research team
  • Summarizing findings into actionable insights
  • Maintaining a comprehensive understanding of relevant therapeutic markets
  • Managing external vendors and consultants
  • Mentoring market research team members
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's launch of Magnolia's Guide to Adventuring showcases their innovative approach to raising disease awareness and redefining perceptions of Rett syndrome.
  • The acceptance of trofinetide for priority review by Health Canada could lead to significant market expansion and first-mover advantage in treating Rett syndrome in Canada.
  • The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development, signals a strong commitment to advancing their R&D capabilities.

What critics are saying

  • The failure of the Phase III ADVANCE-2 trial for pimavanserin in schizophrenia highlights the high-risk nature of drug development in the biopharmaceutical sector.
  • Dependence on regulatory approvals, such as the FDA and Health Canada, introduces uncertainty and potential delays in bringing therapies to market.

What makes Acadia Pharmaceuticals Inc. unique

  • Acadia Pharmaceuticals focuses exclusively on neurological disorders, setting it apart from competitors with broader therapeutic areas.
  • Their commitment to corporate social responsibility, including initiatives like the Rett Sibling Scholarship, enhances their reputation and community engagement.
  • Acadia's strategic partnerships and corporate sponsorships amplify their research capabilities and market reach, distinguishing them from competitors who may not leverage such collaborations.
INACTIVE